Patent · US Active

Aminosteroids for the treatment of a PTP1B associated disease

US9546194B2 · kind B2 · utility

5Cited by

2References

10Claims

0Family size

Assignee

Ohr Pharmaceutical Inc. · US

Inventors

Michael McLane · Lansdale, US
Inez Ruiz-White · Mount Laurel, US
W. Lee Maloy · Lansdale, US
Henry Wolfe · Lower Burrell, US

Key dates

Filing date	Apr 19, 2013
Grant date	Jan 17, 2017
Priority date	—
Expiry date	Apr 19, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07J43/003
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application is directed to the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.